-
What are the symptoms of people who re-yang People who re-yang generally return to the yang within a few days
Time of Update: 2022-12-30
4. Eye symptoms:Patients with novel coronavirus pneumonia may experience eye discomfort, and common eye symptoms include itchy eyes, eye pain, conjunctival hyperemia, conjunctival edema, etc.
4. Eye symptoms:Patients with novel coronavirus pneumonia may experience eye discomfort, and common eye symptoms include itchy eyes, eye pain, conjunctival hyperemia, conjunctival edema, etc.
-
Investment and financing in the field of medicine and biology are active, and enterprise innovation will usher in accelerated development
Time of Update: 2022-12-30
Prior to this, Guosen Pharmaceutical also announced the completion of a series B+ financing of nearly 100 million yuan, after the completion of this round of financing, the company will continue to focus on and deepen the clinical research of innovative drugs in cutting-edge pipelines, deepen business and technology, and continue to highlight the advantages in the field of cell and gene therapy (CGT).
-
Xu Haoyu: Life and health enterprises have the responsibility to establish a healthy and civilized concept
Time of Update: 2022-12-30
Boao, November 28, Xinhuanet (Wu Qilong) From November 25 to 28, the 2022 Boao Forum for Chinese Entrepreneurs was held in Boao, Hainan. Xu Haoyu, secretary of the party committee, chairman and gener
-
Tens of billions of markets to be broken! The popularity of "orphan drugs" in China continues to rise
Time of Update: 2022-12-30
In order to encourage domestic pharmaceutical companies to increase the research and development and production of rare disease drugs, in recent years, national government departments have successively issued a series of incentive policies.
-
Up more than 14% in early trading! This pharmaceutical stock has earned enough eyeballs because of "ibuprofen"
Time of Update: 2022-12-30
In addition, on December 12, Shisi Pharmaceutical Group released news that its products such as Arbidol and azithromycin were listed as domestic anti-epidemic household backup drugs.
In addition, on December 12, Shisi Pharmaceutical Group released news that its products such as Arbidol and azithromycin were listed as domestic anti-epidemic household backup drugs.
-
Ascletis Pharmaceutical, Clover and other B-class pharmaceutical stocks strengthened
Time of Update: 2022-12-30
According to the data, Clover is a biotechnology company in the clinical trial stage, committed to developing novel vaccine and biotherapeutic product candidates for infectious diseases, cancer and autoimmune diseases.
-
The pharmaceutical sector continues to diverge! Northeast Pharmaceutical 6 days 4 boards, Shu Taishen and other bucked the trend
Time of Update: 2022-12-30
Northeast Pharmaceutical, which recently attracted attention due to "2 yuan and 20 tablets of antipyretic drugs", rose again after the opening on December 20, achieving "6 days and 4 boards", as of the close of the day, the stock rose 10.
-
This pharmaceutical stock was surveyed by more than 100 institutions in 2 days!
Time of Update: 2022-12-30
In recent years, thanks to the significant increase in sales of protective products in medical consumables, the company's performance has also ushered in explosive growth.
In recent years, thanks to the significant increase in sales of protective products in medical consumables, the company's performance has also ushered in explosive growth.
-
Issued a notice on the work plan of health services for key groups of the new crown
Time of Update: 2022-12-30
Civil affairs departments are responsible for guiding nursing homes, child welfare institutions and other key places to strengthen management, mobilizing communities (villages) to do a good job in managing key populations under the unified leadership of local epidemic prevention and control mechanisms, and guiding residents' (village) committees to cooperate with grassroots medical and health institutions to provide medicines, antigen tests, and contact higher-level hospitals around the elderly and other high-risk groups.
-
In the past half month, the market price of some medicinal materials has nearly doubled
Time of Update: 2022-12-30
In addition, some people said that with the optimization of epidemic prevention and control policies, coupled with the significant increase in people's demand for seasonal standing drugs in winter, drug manufacturers have concentrated on purchasing raw materials of Chinese medicinal materials, resulting in the opening of the 'fast-moving consumer goods' model from APIs to finished products to chain pharmacies, and the market prices of Chinese medicinal materials for heat and detoxification continue to rise.
-
Leebang @RSNA 2022, open the multi-layout of smart ultrasound!
Time of Update: 2022-12-30
Create a global localized closed-loop ecological chainThe ultrasound business continues to grow rapidlyAs an "old friend" of RSNA, Lee Bon has shown the world the latest technological breakthroughs and innovative achievements of Lipon Ultrasound, which on the other hand reflects the hard power of Lee Bon's global localization.
-
Sales of cold medicine, antiviral, antigen reagents are hot! Positive for pharmacies' Q4 recovery
Time of Update: 2022-12-30
In addition, the heads of listed pharmacy chains said that the current demand for new crown antigen test kits is large, and they are actively communicating with suppliers to step up the supply of reserve supplies.
-
China Pharmaceutical closed 3 consecutive limit boards! The stock has risen 23 times in the past year
Time of Update: 2022-12-30
In order to strengthen Paxlovid's supply in the Chinese market, in addition to reaching cooperation with China Pharmaceutical, Huahai Pharmaceutical announced on August 18 that it reached a production and supply agreement with Pfizer.
-
Netizens "corrected" Lianhua Qingwei? Demystifying the mystery behind the "misunderstanding"
Time of Update: 2022-12-30
Another question appeared in the introduction of the indications, Lianhua Qingwen packaging box and instructions show that "used to treat influenza is a heat poisonous attack lung certificate", some people questioned whether the "certificate" here should be "symptoms"?In this regard, Director Cui Hongsheng explained that the "evidence" and "disease" in Chinese medicine have different connotations.
-
Moving forward in the direction guided by Jingqi - a record of the extraordinary development of Yangzijiang Pharmaceutical Group in ten years
Time of Update: 2022-12-30
Author: China Medical News Feng Yuhao"The report of the 20th National Congress of the Communist Party of China put forward important expressions such as 'high-quality development is the primary task
-
The first China Young Doctors' Minimally Invasive Ablation Professional Skills Competition in South China is about to start
Time of Update: 2022-12-30
Announcement of the event11:10-11:15 Results announced Moderator11:15-11:25 Mentor group11:25-11:30 Competition Summary Professor Xiao YueyongHostInterventional Minimally Invasive Treatment Professional Committee of China Medical Education AssociationMinimally Invasive Tumor Treatment Professional Committee of Chinese Anti-Cancer AssociationAsian Society of CryotherapyAssistedNanjing Yigao Medical Technology Co.
-
Beijing makes every effort to ensure the supply of medical supplies On the 12th, 25 million antigen reagents were released at one time
Time of Update: 2022-12-30
At present, the epidemic situation in Beijing is still at a high level, and the demand for epidemic prevention and control drugs and medical devices has increased sharply. Wang Houting, deputy direct
-
There is a large space for domestic substitution of pharmaceutical equipment, and pharmaceutical companies have rushed to the market!
Time of Update: 2022-12-30
Chuangzhi Technology plans to invest 550 million yuan this time, and the funds raised will be used for high-end pharmaceutical equipment industrialization construction projects, R&D center construction projects, and supplementary working capital.
-
Guangshengtang and other 10 pharmaceutical stocks rose to the limit, and the industry believes that the sector will meet the opportunity
Time of Update: 2022-12-30
, a subsidiary of its innovative drug holding company, was successfully enrolled in the drug administration on March 11, 2022, marking that the clinical trial of GST-HG151 project has entered the substantive development stage 。 In addition, in December 21, Fujian Guangsheng Zhonglin Biotechnology Co.
-
The number of people vaccinated with the third dose of the new crown vaccine in Japan accounts for 67.4% of the country's total population
Time of Update: 2022-12-30
(End) According to the latest data released by the Japanese government on the 19th, the number of people who have completed the third dose of the new crown vaccine in Japan is 84911922, accounting for 67.
